Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis

Nitin J. Karandikar, Carol L. Vanderlugt, Todd Eagar, Litjen Tan, Jeffrey A. Bluestone, Stephen D. Miller

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

B7/CD28-mediated costimulation is a promising target for therapeutic intervention in autoimmune diseases. However, studies addressing the differential functional roles of B7-1 and B7-2 in several autoimmune models have resulted in conflicting data, perhaps due to the temporal dynamics of B7-1 and B7-2 surface expression on different cell types and/or at different sites during an autoimmune response. We examined the temporal expression of B7 costimulatory molecules in the CNS and in various lymphoid organs during the course of murine relapsing-remitting experimental autoimmune encephalomyelitis (R-EAE). Following immunization of SJL mice with the immunodominant proteolipid protein epitope, PLP139-151, surface expression of B7-1 was up-regulated on B cells, T cells, and macrophages, relative to B7- 2, on CNS-infiltrating cells and on splenocytes. Similar enhancement in splenic B7-1 expression could be induced in SJL mice by the adoptive transfer of PLP139-151-specific cells or by immunization with CFA alone. These changes were not observed on lymph node cells, including those isolated from lymph nodes draining the immunization site, which maintained the predominant B7-2 expression pattern seen in naive mice. These phenotypic expression patterns correlated with the functional predominance of B7-1 in costimulating T cell activation when employing APCs from the spleen or CNS of mice with ongoing R- EAE, while B7-2 remained functionally predominant on lymph node Arcs. Variation of phenotypic expression and functional dominance of costimulatory molecule expression in different lymphoid compartments during an active inflammatory autoimmune response has important implications in immune regulation, autoimmune pathogenesis, and therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)192-199
Number of pages8
JournalJournal of Immunology
Volume161
Issue number1
StatePublished - 1998

Fingerprint

Autoimmune Experimental Encephalomyelitis
Up-Regulation
Immunization
Lymph Nodes
Autoimmunity
B7 Antigens
Proteolipids
T-Lymphocytes
Adoptive Transfer
Autoimmune Diseases
Epitopes
B-Lymphocytes
Spleen
Macrophages
Therapeutics
Proteins

ASJC Scopus subject areas

  • Immunology

Cite this

Karandikar, N. J., Vanderlugt, C. L., Eagar, T., Tan, L., Bluestone, J. A., & Miller, S. D. (1998). Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. Journal of Immunology, 161(1), 192-199.

Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. / Karandikar, Nitin J.; Vanderlugt, Carol L.; Eagar, Todd; Tan, Litjen; Bluestone, Jeffrey A.; Miller, Stephen D.

In: Journal of Immunology, Vol. 161, No. 1, 1998, p. 192-199.

Research output: Contribution to journalArticle

Karandikar, NJ, Vanderlugt, CL, Eagar, T, Tan, L, Bluestone, JA & Miller, SD 1998, 'Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis', Journal of Immunology, vol. 161, no. 1, pp. 192-199.
Karandikar, Nitin J. ; Vanderlugt, Carol L. ; Eagar, Todd ; Tan, Litjen ; Bluestone, Jeffrey A. ; Miller, Stephen D. / Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. In: Journal of Immunology. 1998 ; Vol. 161, No. 1. pp. 192-199.
@article{1ae8f600a1d5456d92e437e0a4863182,
title = "Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis",
abstract = "B7/CD28-mediated costimulation is a promising target for therapeutic intervention in autoimmune diseases. However, studies addressing the differential functional roles of B7-1 and B7-2 in several autoimmune models have resulted in conflicting data, perhaps due to the temporal dynamics of B7-1 and B7-2 surface expression on different cell types and/or at different sites during an autoimmune response. We examined the temporal expression of B7 costimulatory molecules in the CNS and in various lymphoid organs during the course of murine relapsing-remitting experimental autoimmune encephalomyelitis (R-EAE). Following immunization of SJL mice with the immunodominant proteolipid protein epitope, PLP139-151, surface expression of B7-1 was up-regulated on B cells, T cells, and macrophages, relative to B7- 2, on CNS-infiltrating cells and on splenocytes. Similar enhancement in splenic B7-1 expression could be induced in SJL mice by the adoptive transfer of PLP139-151-specific cells or by immunization with CFA alone. These changes were not observed on lymph node cells, including those isolated from lymph nodes draining the immunization site, which maintained the predominant B7-2 expression pattern seen in naive mice. These phenotypic expression patterns correlated with the functional predominance of B7-1 in costimulating T cell activation when employing APCs from the spleen or CNS of mice with ongoing R- EAE, while B7-2 remained functionally predominant on lymph node Arcs. Variation of phenotypic expression and functional dominance of costimulatory molecule expression in different lymphoid compartments during an active inflammatory autoimmune response has important implications in immune regulation, autoimmune pathogenesis, and therapeutic strategies.",
author = "Karandikar, {Nitin J.} and Vanderlugt, {Carol L.} and Todd Eagar and Litjen Tan and Bluestone, {Jeffrey A.} and Miller, {Stephen D.}",
year = "1998",
language = "English (US)",
volume = "161",
pages = "192--199",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "1",

}

TY - JOUR

T1 - Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis

AU - Karandikar, Nitin J.

AU - Vanderlugt, Carol L.

AU - Eagar, Todd

AU - Tan, Litjen

AU - Bluestone, Jeffrey A.

AU - Miller, Stephen D.

PY - 1998

Y1 - 1998

N2 - B7/CD28-mediated costimulation is a promising target for therapeutic intervention in autoimmune diseases. However, studies addressing the differential functional roles of B7-1 and B7-2 in several autoimmune models have resulted in conflicting data, perhaps due to the temporal dynamics of B7-1 and B7-2 surface expression on different cell types and/or at different sites during an autoimmune response. We examined the temporal expression of B7 costimulatory molecules in the CNS and in various lymphoid organs during the course of murine relapsing-remitting experimental autoimmune encephalomyelitis (R-EAE). Following immunization of SJL mice with the immunodominant proteolipid protein epitope, PLP139-151, surface expression of B7-1 was up-regulated on B cells, T cells, and macrophages, relative to B7- 2, on CNS-infiltrating cells and on splenocytes. Similar enhancement in splenic B7-1 expression could be induced in SJL mice by the adoptive transfer of PLP139-151-specific cells or by immunization with CFA alone. These changes were not observed on lymph node cells, including those isolated from lymph nodes draining the immunization site, which maintained the predominant B7-2 expression pattern seen in naive mice. These phenotypic expression patterns correlated with the functional predominance of B7-1 in costimulating T cell activation when employing APCs from the spleen or CNS of mice with ongoing R- EAE, while B7-2 remained functionally predominant on lymph node Arcs. Variation of phenotypic expression and functional dominance of costimulatory molecule expression in different lymphoid compartments during an active inflammatory autoimmune response has important implications in immune regulation, autoimmune pathogenesis, and therapeutic strategies.

AB - B7/CD28-mediated costimulation is a promising target for therapeutic intervention in autoimmune diseases. However, studies addressing the differential functional roles of B7-1 and B7-2 in several autoimmune models have resulted in conflicting data, perhaps due to the temporal dynamics of B7-1 and B7-2 surface expression on different cell types and/or at different sites during an autoimmune response. We examined the temporal expression of B7 costimulatory molecules in the CNS and in various lymphoid organs during the course of murine relapsing-remitting experimental autoimmune encephalomyelitis (R-EAE). Following immunization of SJL mice with the immunodominant proteolipid protein epitope, PLP139-151, surface expression of B7-1 was up-regulated on B cells, T cells, and macrophages, relative to B7- 2, on CNS-infiltrating cells and on splenocytes. Similar enhancement in splenic B7-1 expression could be induced in SJL mice by the adoptive transfer of PLP139-151-specific cells or by immunization with CFA alone. These changes were not observed on lymph node cells, including those isolated from lymph nodes draining the immunization site, which maintained the predominant B7-2 expression pattern seen in naive mice. These phenotypic expression patterns correlated with the functional predominance of B7-1 in costimulating T cell activation when employing APCs from the spleen or CNS of mice with ongoing R- EAE, while B7-2 remained functionally predominant on lymph node Arcs. Variation of phenotypic expression and functional dominance of costimulatory molecule expression in different lymphoid compartments during an active inflammatory autoimmune response has important implications in immune regulation, autoimmune pathogenesis, and therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=0031802828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031802828&partnerID=8YFLogxK

M3 - Article

VL - 161

SP - 192

EP - 199

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 1

ER -